Synapse - Nancy Kernan

Results (512)

Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia

Journal Article

Chaudhury, S.; Auerbach, A. D.; Kernan, N. A.; Small, T. N.; Prockop, S. E.; Scaradavou, A.; Heller, G.; Wolden, S.; O'Reilly, R. J.; Boulad, F.
British Journal of Haematology (2008)

Fulltext@MSK | Save

Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings

Journal Article

Castro-Malaspina, H.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Hsu, K.; Chiu, M.; more...
Biology of Blood and Marrow Transplantation (2008)

Fulltext@MSK | Save

The National Marrow Donor Program 20 years of unrelated donor hematopoietic cell transplantation

Journal Article

Ballen, K. K.; King, R. J.; Chitphakdithai, P.; Bolan, C. D. Jr; Agura, E.; Hartzman, R. J.; Kernan, N. A.
Biology of Blood and Marrow Transplantation (2008)

Fulltext@MSK | Save

CD34+viability is a critical determinant of the engraftment potential of umbilical cord blood (UCB) in double unit transplantation

Meeting Abstract

Scaradavou, A.; Smith, K.; Hawke, R.; Lee, S.; Schaible, A.; Abboud, M.; Collins, N.; Kernan, N. A.; Van Den Brink, M.; Barker, J. N.
Blood (2007)

Fulltext@MSK | Save

Effect of graft engineering and post-transplantation immunosuppression regimen on immunophenotypic recovery in recipients of unrelated donor bone marrow (T-Cell depletion trial) in a multicenter randomized phase II-III trial

Meeting Abstract

Lamb, L. S.; Wagner, J. E.; Kernan, N. A.; Small, T. N.; Carter, S. L.; Thompson, J. S.; Cloud, G. A.; Meleth, S.; Kumar, A.; Keever-Taylor, C. A.
Blood (2007)

Fulltext@MSK | Save

Recent decrease in acute GVHD and increased relapse in children with leukemia receiving unrelated donor bone marrow transplants

Meeting Abstract

Davies, S. M.; Wang, D.; Wang, T.; Arora, A.; Ringden, O.; Anasetti, C.; Pavletic, S.; Casper, J.; MacMillan, M. L.; Sanders, J.; more...
Blood (2007)

Fulltext@MSK | Save

Phase II trial of a chemotherapy-only regimen of busulfan, melphalan, fludarabine and R-ATG followed by allogeneic T-cell depleted (TCD) hematopoietic stem cell transplants (HSCT) for the treatment of myeloid malignancies

Meeting Abstract

Boulad, F.; Jakubowski, A.; Papadopoulos, E.; Hsu, K. C.; Perales, M. A.; Van Den Brink, M.; Young, J. W.; Chiu, M.; Kernan, N. A.; Prockop, S. E.; more...
Blood (2007)

Fulltext@MSK | Save

Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: Analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent craft-versus-host disease

Journal Article

van Burik, J. A. H.; Carter, S. L.; Freifeld, A. G.; High, K. P.; Godder, K. T.; Papanicolaou, G. A.; Mendizabal, A. M.; Wagner, J. E.; Yanovich, S.; Kernan, N. A.
Biology of Blood and Marrow Transplantation (2007)

Fulltext@MSK | Save

Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies

Journal Article

Small, T. N.; Young, J. W.; Castro-Malaspina, H.; Prockop, S.; Wilton, A.; Heller, G.; Boulad, F.; Chiu, M.; Hsu, K.; Jakubowski, A.; more...
Biology of Blood and Marrow Transplantation (2007)

Fulltext@MSK | Save

Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease

Journal Article

Perales, M. A.; Ishill, N.; Lomazow, W. A.; Weinstock, D. M.; Papadopoulos, E. B.; Dastigir, H.; Chiu, M.; Boulad, F.; Castro-Malaspina, H. R.; Heller, G.; more...
Bone Marrow Transplantation (2007)

Fulltext@MSK | Save